Naruko Suzuki Junji Hiraga Hiroki Kato Yusuke Takagi Nobuko Ujihira Michihiko Narita Yoshitoyo Kagami
10.2169/internalmedicine.56.7865
Intern Med
2017;56(13):1711-1713.
azacitidine myelodysplastic syndrome secondary malignancy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28674363/
Lymphoma, Large B-Cell, Diffuse / pathology Myelodysplastic Syndromes / pathology Neoplasms, Second Primary / pathology
Lymphoma, Large B-Cell, Diffuse / pathology Myelodysplastic Syndromes / pathology Neoplasms, Second Primary / pathology Case Reports Azacitidine / therapeutic use Humans Lymphoma, Large B-Cell, Diffuse / diagnosis Male Middle Aged Myelodysplastic Syndromes / drug therapy Azacitidine
PMC5519476
28674363
EBV-positive Diffuse Large B-cell Lymphoma as a Secondary Malignancy Arising in a Myelodysplastic Syndrome Patient who Was Treated with Azacitidine
2017